Navigation Links
Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
Date:12/4/2009

ume flexible I.V. container to feature a full line of sizes without an overwrap, and the product also offers patient and caregiver safety benefits, such as sterile, virtually impenetrable medication additive port tubes and a flanged port design to help protect against needlesticks. The containers also provide a greater protective area for clinicians as they add medications to the container. The VisIV product line also offers other safety features, such as ergonomic pull rings to prevent touch contamination and superior barcode reading.

"Using VisIV containers in Health Alliance hospitals is a key element of our waste reduction strategy and superior patient care," said Shelly Wiest, director of clinical pharmacy programs for Health Alliance, a network of five hospitals in greater Cincinnati. "All of the VisIV container's innovative features were designed to help improve the safety and efficiency of intravenous medication delivery, so we know we are doing the best for our patients as well as for the environment when we use VisIV."

Hospira introduced the VisIV container in 2006 as a greener alternative to traditional I.V. bags. Approximately 1,400 of the 5,708 hospitals in the United States, or nearly 25 percent, use VisIV for some or most of their I.V. needs, resulting in the elimination of more than 1.4 million pounds of plastic waste since launch.(iv) Should the entire industry follow Hospira's lead and eliminate overwrap from all flexible I.V. containers, more than 20 million pounds of plastic could be eliminated from the U.S. hospital waste stream each year.(v)

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication mana
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
2. Hospira Reports Third-Quarter 2009 Results
3. Hospira Names Daphne E. Jones Chief Information Officer
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
6. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
7. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
8. Codexis Expands Collaboration with Teva
9. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
10. Sarnova Expands Senior Management Team
11. Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16% as CMS Reimbursement Expands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014 / -- China Nepstar Chain Drugstore Ltd. (NYSE: ... leading retail drugstore chain in China ... today announced the appointment of Ms. Rebecca Yingnan ... immediately. Ms.Zhang has over 20 years ... in March 1999. Prior to Ms. Zhang,s appointment as ...
(Date:11/24/2014)... Juno Therapeutics today announced that the ... company,s JCAR015 chimeric antigen receptor product candidate.  The ... refractory B-cell acute lymphoblastic leukemia and was filed ... Center, where Phase 1 clinical trials are currently ... important news for patients who may benefit from ...
(Date:11/24/2014)... YORK , Nov. 24, 2014  Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to present at the LD MICRO "MAIN Event" Micro-Cap ... will be held at the Luxe Sunset Bel Air ... Los Angeles, California . ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Relmada Therapeutics To Present At LD MICRO Conference 2
... NEW YORK, Dec. 6, 2010 Keryx Biopharmaceuticals, ... data presented for the first time at the ... Hematology showing promising clinical activity, safety and tolerability ... leukemia (CLL) and Hodgkin,s lymphoma (HL).  KRX-0401 (perifosine) ...
... L.P. unveiled an enhanced version of its popular educational ... easier for healthcare professionals, people with pain and their ... tools. For more than 17 years, the Partners Against ... the quality of pain management for individuals touched by ...
Cached Medicine Technology:Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 2Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 3Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 4Phase 2 Data Presented at the 52nd Annual Meeting of the American Society of Hematology Demonstrates Promising Efficacy of KRX-0401 (Perifosine) in the Treatment of Advanced Leukemia, Lymphoma and Multiple Myeloma 5Purdue Pharma L.P. Re-launches Partners Against Pain Website 2
(Date:11/26/2014)... (PRWEB) November 26, 2014 Louisiana ... relief and specialists in minimally invasive spine surgery, ... Shamieh into the rapidly growing provider network of ... The addition coincides with the network’s continuing success ... treatment for Louisiana residents who are suffering from ...
(Date:11/26/2014)... 2014 Sonoran Vein and Endovascular ... the Distinguished Preceptorship Award from The American ... in the advancement of nurse practitioners. The Distinguished ... who had made a significant contribution toward increasing ... Association of Nurse Practitioners (AANP) is the largest ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Youngsters who enter ... new study suggests. Early puberty was linked with ... poor self-image and high anxiety levels, according to the ... such as conflict with family and peers, and having ... study found. Although the study found an association ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Teens prescribed anti-anxiety ... abuse those drugs than other teens, a new ... to conduct substance abuse assessments on teenagers before ... "Prescribers and parents don,t realize the abuse ... at the University of Michigan School of Nursing. ...
(Date:11/26/2014)... Exposure to peanut protein in household dust may increase ... skin condition eczema, a new study reveals. About ... are allergic to peanuts. And severe eczema in infants ... the researchers noted. The new study included 359 ... examined the amount of peanut protein the children were ...
Breaking Medicine News(10 mins):Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
... weight loss drugs are really safe, an analysis of previous ... was conducted. What// came to light was the lack of ... ,Two Canadian researchers, Raj Padwal and Sumit Majumdar of ... like sibutramine (Meridia), orlistat (Xenical) and rimonabant (Acomplia) are no ...
... new proposal released by Gov. Arnold Schwarzenegger recently, workers ... double benefit - to their// health and wealth. Employees ... be exempted from tax. ,The proposal is ... is reachable to the approximate 6.5 million Californians who ...
... towards understanding how the human brain learns to recognize ... of Technology, in 2003 launched a project to study ... Prakash" aims to study, identify and, treat, children who ... a lady born blind was studied by the professor, ...
... India plans to promote the development of public-private partnerships ... the National AIDS Control Programme (NACP-III) is likely to ... that approx. 80 per cent of the Indians seek ... per cent for inpatient care. ,A national ...
... diabetes mellitus (NODM) develops in certain patients following a liver ... to develop//, finds that all the risk factors can be ... tailored to the patient's risk ,They found the ... and hepatitis C infection (HCV) paired with the use of ...
... Prevention (CDC) Atlanta's Division of Tuberculosis Elimination feel that ... made TB tests mandatory for all foreign-born nationals, irrespective ... ,Tuberculosis can only be eradicated if all foreign-born ... treated for latent TB infection, they say. ...
Cached Medicine News:Health News:Latest Research on Visual Skills is an Eye Opener 2Health News:Risk Factors That Cause NODM After A Liver Transplant 2Health News:All Foreign-born Nationals In US To Be Tested For TB 2
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large devices for vascular intervention....
Used to introduce balloon, closed and non-tapered end catheters and other devices for intervention....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: